Skip to main content
Premium Trial:

Request an Annual Quote

VWR to Distribute Kapa Biosystems' PCR Reagents in North America


Kapa Biosystems said this week that VWR International will distribute its PCR reagents in North America under a non-exclusive agreement.

The agreement gives VWR the rights to distribute Kapa's portfolio of products for applications such as high-fidelity PCR, fast PCR, long-range PCR, whole-blood PCR, crude-sample PCR, and single-protocol PCR.

Kapa said that its reagents are based on DNA polymerases that have been engineered to possess "unique amino acid modifications that confer dramatic improvements to the function of the enzymes."

The company's optimized polymerases include: KAPA2G FAST DNA Polymerase, which Kapa said is capable of synthesizing DNA in 50 percent less time than standard polymerase with high sensitivity; KAPA2G ROBUST DNA Polymerase, which is "more processive and tolerant of common PCR inhibitors carried over from DNA extraction;" KAPA HiFi DNA Polymerase, which exhibits "strong proofreading capability;" and KAPA Blood DNA Polymerase, which is able to amplify DNA direct from whole blood without the need for extraction.

VWR is a global laboratory supply and distribution company that recorded worldwide revenues of more than $3.7 billion in 2008.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.